Search clinical trials for: Recombinant birch pollen

Total 3083 results

Stallergenes Greer

Terminated

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Allergy

France
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

Allergy

Germany
Fraunhofer-Institute of Toxicology and Experimental...

Recruiting

Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis (UBAMBI)

Allergic Rhinitis | Seasonal Allergic Rhinitis | Birch Pollen Allergy | Ragweed Allergy

Germany
Royal Sussex County Hospital

Unknown

Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?

Oral Allergy Syndrome

United Kingdom
Queen's University
University of British Columbia

Completed

Clinical Validation of Birch Pollen in the EEU

Allergic Rhinitis

Canada
Fraunhofer-Institute of Toxicology and Experimental...

Completed

Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)

Seasonal Allergic Rhinitis
Helsinki University Central Hospital
University of Helsinki; Finnish Institute of Occupational Health

Completed

The Effects of Immunotherapy in the Nose (Birch11)

Rhinitis, Allergic, Seasonal
Alyatec

Completed

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Allergic Conjunctivitis

France
Karolinska Institutet

Completed

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

Asthma | Allergy | Rhinitis
Stallergenes Greer
Quintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT Corporation

Completed

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Hypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal Allergy

Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital; Sodra Alvsborgs Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

Rhinitis, Allergic

Sweden
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Allergy

Germany
The University of Texas Medical Branch, Galveston

Completed

Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber (Pollen)

Allergic Rhinitis
University of Zurich

Completed

Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration

Rhinoconjunctivitis

Switzerland
Oulu University Hospital

Unknown

Effect of the Nasal Provocation on the Breathing Style

Birch Pollen Allergy | Healthy Control Subjects

Finland
Graminex LLC
KGK Science Inc.

Completed

The Efficacy of Graminex® Flower Pollen Extracts in Healthy Women With Urinary Incontinence

Urinary Incontinence

Canada
Mahidol University

Completed

Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts and Specific IgE

Immediate Type Hypersensitivity
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, Substudy

Rhinitis, Allergic, Seasonal

Sweden
GlaxoSmithKline

Completed

Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958

Asthma and Rhinitis

Canada
Cindy Elizabeth de Lira-Quezada
Medicina

Recruiting

Environmental Pollutants and Their Effects on Respiratory Allergy

Allergic Rhinitis | Pollution; Exposure | Allergic Asthma

Mexico
University Hospital, Strasbourg, France

Completed

Resolution of Allergic Inflammation

Grass Pollen Allergic Rhinitis

France
Alyatec

Completed

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber

Allergic Rhinitis Due to Grass Pollen

France
Roxall Medicina España S.A

Completed

A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica

Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain
Johann Wolfgang Goethe University Hospital

Completed

Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen

Hypersensitivity | Allergy | Bronchial Hyperreactivity | Bronchial Asthma

Germany
Fraunhofer-Institute of Toxicology and Experimental...

Completed

The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit

Asthma | Seasonal Allergic Rhinitis

Germany
Artu Biologicals

Completed

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
Artu Biologicals

Unknown

A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Netherlands, United Kingdom, Germany, Poland, Belgium, France
Fraunhofer-Institute of Toxicology and Experimental...

Completed

A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions

Healthy Subjects | Seasonal Allergic Rhinitis

Germany
MASK-air SAS

Completed

Interaction Between Air Pollution, Pollens and Allergic Rhinitis (MISTRAL)

Allergic Rhinitis Due to Pollen | Allergic Rhinitis With Asthma

France
Circassia Limited
Quintiles, Inc.; Adiga Life Sciences, Inc.

Completed

Birch-SPIRE Safety and Efficacy Study

Rhinitis

Canada
HAL Allergy

Completed

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

Belgium, Germany, Czech Republic, Poland, Slovakia
Dr. Santiago Palacios

Completed

Effect of Pollen Extract on Urinary Incontinence

Urinary Incontinence

Spain
Johann Wolfgang Goethe University Hospital

Completed

Safety and Repeatability of Bronchial Challenge With Grass-pollen

Allergic Asthma

Germany
University Hospital, Ghent

Completed

Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes

Breast Cancer | Hot Flashes | Postmenopausal Symptoms

Belgium
Amber Patterson
Nationwide Children's Hospital

Unknown

Safety of Lymph Node Injection for Allergen Immunotherapy

Allergic Rhinitis

United States
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of Ragweed SLIT Tablets

Rhinitis, Allergic, Seasonal | Ragweed Pollen Allergy

Hungary
Allergy Therapeutics

Completed

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Type I Hypersensitivity

Germany
HAL Allergy

Completed

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland, Czech Republic, Germany
Royal Sussex County Hospital

Terminated

Mechanisms of Allergen Immunotherapy

Allergic Rhinitis

United Kingdom
Fraunhofer-Institute of Toxicology and Experimental...
Hannover Medical School

Completed

Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis (Neurop)

Atopic Dermatitis
Aarhus University Hospital
University of Aarhus; University Hospital, Linkoeping

Active, not recruiting

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy (ILITNU)

Allergic Rhinitis Due to Grass Pollen | Allergic Asthma | Allergic Conjunctivitis of Both Eyes

Denmark, Sweden
Amryt Pharma
Chiesi Farmaceutici S.p.A.

Not yet recruiting

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez (FOSteR)

Epidermolysis Bullosa, Junctional | Epidermolysis Bullosa, Dystrophic
ALK-Abelló A/S

Completed

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

Allergy

Germany
Leti Pharma GmbH

Completed

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) Pollen

Germany
HAL Allergy
Ergomed

Completed

PURETHAL Birch RUSH Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland
Lars Olaf Cardell

Completed

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

Allergic Rhinitis

Sweden

Search clinical trials for: Recombinant birch pollen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations